Miles to Go on the SCENIC Route: Should Chromoendoscopy Become the Standard of Care in IBD Surveillance?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 26148262.
- Also identified by DOI 10.1038/ajg.2015.179.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The recent SCENIC Consensus statement has raised questions about which patients with chronic colitis should receive chromoendoscopic surveillance. Two papers in this issue of the American Journal of Gastroenterology provide more evidence and context, and this editorial discusses the current evidence base, which patients might benefit from chromoendoscopy, and what more evidence is needed before chromoendoscopy can be considered a possible new standard of care in all patients with chronic colitis.
Medical subject headings
- Biopsy
- Cell Transformation, Neoplastic
- Colitis, Ulcerative
- Colon
- Colonoscopy
- Colorectal Neoplasms
- Early Detection of Cancer
- Inflammatory Bowel Diseases
- Mass Screening
- Population Surveillance